What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Hypovitaminosis D common in SLE
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
21 A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study Annals of Rheumatic Diseases, May 21, 2013 Clinical Article
22 Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study Annals of Rheumatic Diseases, May 21, 2013 Clinical Article
23 Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis Current Drug Targets, May 21, 2013 Clinical Article
24 The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations Annals of Rheumatic Diseases, May 21, 2013 Review Article
25 Readability and suitability assessment of patient education materials in rheumatic diseases Arthritis Care & Research , May 21, 2013 Clinical Article
26 Characterisation of hand small joints arthropathy using high-resolution MRI--Limited discrimination between osteoarthritis and psoriatic arthritis European Radiology, May 21, 2013 Clinical Article
27 Validation of methotrexate-first strategy in early poor prognosis rheumatoid arthritis: Results from a randomized, double-blind, 2-year trial Arthritis & Rheumatism, May 20, 2013 Clinical Article
28 The Role of Microparticles in the Pathogenesis of Rheumatoid Arthritis and SLE Scandinavian Journal of Immunology, May 20, 2013 Clinical Article
29 Sonographic joint assessment in rheumatoid arthritis: Associations with clinical joint assessment in remission Arthritis & Rheumatism, May 20, 2013 Clinical Article
30 Lung Involvement in Connective Tissue Diseases: A Comprehensive Review and A Focus On Rheumatoid Arthritis Autoimmunity Reviews, May 17, 2013 Clinical Article
31 Does rheumatoid arthritis have an effect on audiovestibular tests European Archives of Oto-Rhino-Laryngology, May 17, 2013 Clinical Article
32 Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany Full Text Open Access Rheumatology: Research and Reviews, May 17, 2013 Clinical Article
33 Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 2 Years of the GO-FORWARD Study Extension The Journal of Rheumatology, May 16, 2013 Clinical Article
34 Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis The Journal of Rheumatology, May 16, 2013 Clinical Article
35 Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis Rheumatology International, May 16, 2013 Clinical Article
36 Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors Clinical Rheumatology, May 16, 2013 Clinical Article
37 Angiogenesis in rheumatoid arthritis is directly fostered by TLR5 ligation and indirectly through IL-17 induction Arthritis & Rheumatism, May 16, 2013 Review Article
38 Association between tumor necrosis factor-α (TNF-α) promoter -308 G/A and response to TNF-α blockers in rheumatoid arthritis: a meta-analysis Modern Rheumatology, May 15, 2013 Evidence Based Medicine Review Article Clinical Article
39 The role of vitamin D supplementation in patients with rheumatic diseases Nature Reviews Rheumatology , May 15, 2013 Clinical Guideline Clinical Article
40
JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical
Modern Rheumatology, May 14, 2013
Clinical Article
Exclusive Author Commentary
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summary1 The new European League Against Rheumatism/American College of Rheumatology diagnostic criteria for rheumatoid arthritis: how are they performing Current Opinion in Rheumatology, April 4, 2013
2 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Annals of Rheumatic Diseases, April 10, 2013
3 New methods for determining comparative effectiveness in rheumatoid arthritis Current Opinion in Rheumatology, April 3, 2013
4 Rheumatoid arthritis in the elderly: recent advances in understanding the pathogenesis, risk factors, comorbidities and risk-benefit of treatments Aging Health, April 11, 2013 Review Article
5 Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis Annals of Rheumatic Diseases, April 22, 2013 Evidence Based Medicine Review Article
6 Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial The Journal of Rheumatology, April 18, 2013
7 Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis Rheumatology International, April 5, 2013
8 Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study The Journal of Rheumatology, April 2, 2013
9 The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis (RA) vs. non-RA subjects: Results from a population-based study Arthritis Care & Research , April 17, 2013
10 Treatment strategies for early rheumatoid arthritis Current Opinion in Rheumatology, April 1, 2013
11 Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study The Journal of Rheumatology, April 2, 2013
12 Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study Annals of Rheumatic Diseases, April 9, 2013
13 Does Acetaminophen Activate Endogenous Pain Inhibition in Chronic Fatigue Syndrome/Fibromyalgia and Rheumatoid Arthritis? A Double-Blind Randomized Controlled Cross-over Trial Pain Physician, March 25, 2013 Free full text
14 Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data Modern Rheumatology, April 9, 2013
15 Adalimumab: 8 years of experience in rheumatoid arthritis International Journal of Clinical Rheumatology, April 2, 2013
16 A simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritis Rheumatology, April 19, 2013
17 What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review Annals of Rheumatic Diseases, April 23, 2013 Evidence Based Medicine Review Article
18 Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program The Journal of Rheumatology, April 16, 2013
19 Oral administration of GLPG0259, an inhibitor of MAPKAPK5, a new target for the treatment of rheumatoid arthritis: a phase II, randomised, double-blind, placebo-controlled, multicentre trial Annals of Rheumatic Diseases, April 8, 2013
20 Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States Arthritis Care & Research , April 2, 2013
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close